These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32100534)

  • 1. Gut Microbiome-Based Diagnostic Model to Predict Coronary Artery Disease.
    Zheng YY; Wu TT; Liu ZQ; Li A; Guo QQ; Ma YY; Zhang ZL; Xun YL; Zhang JC; Wang WR; Kadir P; Wang DY; Ma YT; Zhang JY; Xie X
    J Agric Food Chem; 2020 Mar; 68(11):3548-3557. PubMed ID: 32100534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
    Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
    Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the gut microbiome and metabolism with coronary artery disease severity.
    Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C
    Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic model for predicting hyperuricemia based on alterations of the gut microbiome in individuals with different serum uric acid levels.
    Liang M; Liu J; Chen W; He Y; Kahaer M; Li R; Tian T; Liu Y; Bai B; Cui Y; Yang S; Xiong W; Ma Y; Zhang B; Sun Y
    Front Endocrinol (Lausanne); 2022; 13():925119. PubMed ID: 36237183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiome as non-invasive biomarkers for identifying overweight people at risk for osteoarthritis.
    Wang Z; Zhu H; Jiang Q; Zhu YZ
    Microb Pathog; 2021 Aug; 157():104976. PubMed ID: 34023440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome-based noninvasive diagnostic model to predict acute coronary syndromes.
    Wang J; Hu Z; Xu Q; Shi Y; Cao X; Ma Y; Wang M; Zhang C; Luo X; Lin F; Li X; Duan Y; Cai H
    Front Cell Infect Microbiol; 2023; 13():1305375. PubMed ID: 38298920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the gut mycobiome with coronary artery disease severity.
    An K; Jia Y; Xie B; Gao J; Chen Y; Yuan W; Zhong J; Su P; Liu X
    EBioMedicine; 2024 May; 103():105137. PubMed ID: 38703606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery disease is associated with an altered gut microbiome composition.
    Toya T; Corban MT; Marrietta E; Horwath IE; Lerman LO; Murray JA; Lerman A
    PLoS One; 2020; 15(1):e0227147. PubMed ID: 31995569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease.
    Yoshida N; Sasaki K; Sasaki D; Yamashita T; Fukuda H; Hayashi T; Tabata T; Osawa R; Hirata KI; Kondo A
    J Atheroscler Thromb; 2019 Aug; 26(8):705-719. PubMed ID: 30587666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine.
    Tian R; Liu HH; Feng SQ; Wang YF; Wang YY; Chen YX; Wang H; Zhang SY
    J Microbiol; 2022 Apr; 60(4):419-428. PubMed ID: 35246806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the diversity of intestinal microbiome and its potential value as a biomarker in patients with schizophrenia: A cohort study.
    Pan R; Zhang X; Gao J; Yi W; Wei Q; Su H
    Psychiatry Res; 2020 Sep; 291():113260. PubMed ID: 32763534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiome Reveals Specific Dysbiosis in Primary Osteoporosis.
    Xu Z; Xie Z; Sun J; Huang S; Chen Y; Li C; Sun X; Xia B; Tian L; Guo C; Li F; Pi G
    Front Cell Infect Microbiol; 2020; 10():160. PubMed ID: 32373553
    [No Abstract]   [Full Text] [Related]  

  • 14. Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.
    Zhang T; Ren H; Du Z; Zou T; Guang X; Zhang Y; Tian Y; Zhu L; Yu J; Yu X; Zhang Z; Dai H
    Microbiol Spectr; 2022 Dec; 10(6):e0280422. PubMed ID: 36301099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
    Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H
    J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?
    Gokulakrishnan K; Nikhil J; Viswanath B; Thirumoorthy C; Narasimhan S; Devarajan B; Joseph E; David AKD; Sharma S; Vasudevan K; Sreeraj VS; Holla B; Shivakumar V; Debnath M; Venkatasubramanian G; Varambally S
    J Psychiatr Res; 2023 Jun; 162():140-149. PubMed ID: 37156128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
    Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI
    Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease.
    Emoto T; Yamashita T; Kobayashi T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata KI
    Heart Vessels; 2017 Jan; 32(1):39-46. PubMed ID: 27125213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiome Distinguishes Patients With Epilepsy From Healthy Individuals.
    Cui G; Liu S; Liu Z; Chen Y; Wu T; Lou J; Wang H; Zou Y; Sun Y; Rao B; Ren Z; Lian Y; Jiang Y
    Front Microbiol; 2021; 12():696632. PubMed ID: 35069460
    [No Abstract]   [Full Text] [Related]  

  • 20. Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
    Deng T; Li J; He B; Chen B; Liu F; Chen Z; Zheng J; Shi Z; Zhang T; Deng L; Yu H; Yang J; Wu L; Shan Y; Yu Z; Chen X; Wang Y; Chen G
    Hepatol Int; 2022 Feb; 16(1):99-111. PubMed ID: 35064546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.